Equillium, Inc. (EQ)
2.20
-0.11
(-4.76%)
USD |
NASDAQ |
Aug 24, 16:00
2.24
+0.04
(+1.82%)
After-Hours: 20:00
Equillium Debt to Equity Ratio : 0.0104 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0104 |
| March 31, 2026 | 0.0116 |
| December 31, 2025 | 0.0251 |
| September 30, 2025 | 0.0241 |
| June 30, 2025 | 0.0512 |
| March 31, 2025 | 0.0279 |
| December 31, 2024 | 0.0201 |
| September 30, 2024 | 0.0214 |
| June 30, 2024 | 0.0271 |
| March 31, 2024 | 0.0341 |
| December 31, 2023 | 0.0365 |
| September 30, 2023 | 0.0384 |
| June 30, 2023 | 0.038 |
| March 31, 2023 | 0.2965 |
| December 31, 2022 | 0.3189 |
| September 30, 2022 | 0.4146 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.2915 |
| March 31, 2022 | 0.2236 |
| December 31, 2021 | 0.1773 |
| September 30, 2021 | 0.1335 |
| June 30, 2021 | 0.1188 |
| March 31, 2021 | 0.1089 |
| December 31, 2020 | 0.1423 |
| September 30, 2020 | 0.1264 |
| June 30, 2020 | 0.3167 |
| March 31, 2020 | 0.2681 |
| December 31, 2019 | 0.2313 |
| September 30, 2019 | 0.1964 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -1.117 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ironwood Pharmaceuticals, Inc. | -2.452 |
| Fortress Biotech, Inc. | 0.3248 |
| Cue Biopharma, Inc. | 3.813 |
| Legend Biotech Corp. | 0.2263 |
| Dianthus Therapeutics, Inc. | 0.0011 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 58.67M |
| Total Liabilities (Quarterly) | 2.65M |
| Shareholders Equity (Quarterly) | 56.02M |
| Current Ratio | 23.40 |
| Net Debt Paydown Yield | -0.03% |